Stock 301033 MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
39.11 CNY +0.85% Intraday chart for Medprin Regenerative Medical Technologies Co., Ltd. +0.18% -10.17%
06-20 Medprin Regenerative Medical Technologies Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 26 June 2024 CI
05-13 Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 4,038 2,436 2,876
Enterprise Value (EV) 1 3,763 2,326 2,710
P/E ratio 77.4 x 68.3 x 70.2 x
Yield 0.16% 0.54% 0.92%
Capitalization / Revenue 26.3 x 12.5 x 12.5 x
EV / Revenue 24.5 x 11.9 x 11.7 x
EV / EBITDA 114 x 60.1 x 40 x
EV / FCF -29.6 x -19.7 x 151 x
FCF Yield -3.38% -5.07% 0.66%
Price to Book 7.06 x 4.04 x 4.52 x
Nbr of stocks (in thousands) 66,063 66,063 66,063
Reference price 2 61.12 36.88 43.54
Announcement Date 20/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 85.75 113.2 123.5 153.8 195.3 230.9
EBITDA 1 -27.47 16.38 30.5 32.87 38.68 67.73
EBIT 1 -30.97 12.03 25.62 27.01 25.74 44.2
Operating Margin -36.12% 10.62% 20.74% 17.56% 13.18% 19.15%
Earnings before Tax (EBT) 1 -19.65 31.06 43 51.6 39.96 48.02
Net income 1 -18.59 27.68 36.97 44.73 35.89 40.88
Net margin -21.68% 24.44% 29.93% 29.09% 18.38% 17.71%
EPS 2 -0.4100 0.5600 0.7500 0.7900 0.5400 0.6200
Free Cash Flow 1 -36.51 -13.71 -26.65 -127.1 -118 17.89
FCF margin -42.58% -12.1% -21.57% -82.67% -60.43% 7.75%
FCF Conversion (EBITDA) - - - - - 26.42%
FCF Conversion (Net income) - - - - - 43.77%
Dividend per Share - - - 0.1000 0.2000 0.4000
Announcement Date 05/07/20 05/07/20 04/07/21 20/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 197 198 170 275 110 166
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -36.5 -13.7 -26.6 -127 -118 17.9
ROE (net income / shareholders' equity) -9.56% 9.54% 11.5% 9.77% 6.06% 6.6%
ROA (Net income/ Total Assets) -8.75% 2.35% 4.06% 2.83% 2.16% 3.61%
Assets 1 212.5 1,178 909.6 1,583 1,664 1,133
Book Value Per Share 2 5.980 6.040 6.780 8.660 9.120 9.630
Cash Flow per Share 2 1.970 0.5700 0.2400 0.1600 0.6800 0.4000
Capex 1 20.1 36.7 61.6 153 136 40.1
Capex / Sales 23.42% 32.42% 49.91% 99.3% 69.63% 17.36%
Announcement Date 05/07/20 05/07/20 04/07/21 20/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD. Stock Medprin Regenerative Medical Technologies Co., Ltd.
-10.17% 352M
STRYKER CORPORATION Stock Stryker Corporation
+13.62% 130B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.08% 10.77B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-18.14% 7.17B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-34.21% 4.02B
AXONICS, INC. Stock Axonics, Inc.
+8.03% 3.44B
ENOVIS CORPORATION Stock Enovis Corporation
-19.31% 2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-18.50% 1.96B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-24.94% 1.67B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-36.36% 1.47B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 301033 Stock
  4. Financials Medprin Regenerative Medical Technologies Co., Ltd.